CM Basavaraj Bommai emphasises cooperation with US in pharma sector

CM Bommai stated that Karnataka has already become a hub of drug research and welcomed more investments by US companies in drug and vaccine production for the world.

Basavaraj Bommai, Karnataka CM
Basavaraj Bommai, Karnataka CM
ANI General News
1 min read Last Updated : Nov 16 2022 | 7:23 AM IST

Chief Minister Basavaraj Bommai emphasized the importance of setting up a working group between US officials and the Karnataka government for increasing pharma-related R & D as well as drug production in the state.

He was interacting with a delegation led by Rahul Gupta, Director of the White House Office of National Drug Control Policy at his Home Office Krishna. Rahul Gupta explained in detail the measures President Joe Biden's Office took to increase cooperation between India and the USA in Drug Policy Formulation and Drug production and in the field of Narcotic Drugs Control.

He agreed to initiate necessary dialogue in this direction and sought the indulgence of CM Bommai to facilitate more investments by US companies in the Pharma sector in Karnataka.

CM Bommai stated that Karnataka has already become a hub of drug research and welcomed more investments by US companies in drug and vaccine production for the world.

The US delegation included Harinder S. Panesar, President of the Global Indian Trade and Cultural Council. N. Manjunath Prasad, Principal Secretary to Chief Minister and Jayaram Raipura, Secretary to CM were present in the meeting.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Basavaraj Somappa BommaiKarnataka governmentUnited Statespharmaceutical firms

First Published: Nov 16 2022 | 7:23 AM IST

Next Story